BERNSTEIN, BARRY M,MENON, RAJEEV M,KHATRI, AMIT,MENSING, SVEN,DUTTA, SANDEEP,COHEN, DANIEL E,PODSADECKI, THOMAS J,BRUN, SCOTT C,AWNI, WALID M,DUMAS, EMILY O,KLEIN, CHERI E
申请号：
PH12014502848
公开号：
PH12014502848A1
申请日:
2014.12.22
申请国别(地区):
PH
年份:
2016
代理人:
摘要：
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin.
